-
Mashup Score: 3
The Circulatory System Devices Panel will meet next week to vote on PMA requests from two manufacturers.
Source: www.tctmd.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
ReCor Medical today applauded updated and expanded recommendations for managing arterial hypertension overseas.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0European guidelines offer support for renal denervation in hypertension, boosting Medtronic, ReCor - 10 month(s) ago
Medtronic hailed the updated guidelines as a “turning point” for the use of renal denervation in treating high blood pressure.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0FDA panel to review renal denervation system PMA submissions - 11 month(s) ago
The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4New Statement for Public Comment | SCAI - 11 month(s) ago
About the Statement Despite the advent of medical therapy for hypertension, population blood pressure control remains suboptimal. Limitations of medical therapy include cost, adverse side effects, limited access, and poor adherence. Renal denervation (RDN) is a minimally invasive, endovascular procedure targeting sympathetic nerves adjacent to the renal arteries. Disruption of these nerves has…
Source: scai.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4New Statement for Public Comment | SCAI - 11 month(s) ago
About the Statement Despite the advent of medical therapy for hypertension, population blood pressure control remains suboptimal. Limitations of medical therapy include cost, adverse side effects, limited access, and poor adherence. Renal denervation (RDN) is a minimally invasive, endovascular procedure targeting sympathetic nerves adjacent to the renal arteries. Disruption of these nerves has…
Source: scai.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4New Statement for Public Comment | SCAI - 11 month(s) ago
About the Statement Despite the advent of medical therapy for hypertension, population blood pressure control remains suboptimal. Limitations of medical therapy include cost, adverse side effects, limited access, and poor adherence. Renal denervation (RDN) is a minimally invasive, endovascular procedure targeting sympathetic nerves adjacent to the renal arteries. Disruption of these nerves has…
Source: scai.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2New Statement for Public Comment | SCAI - 11 month(s) ago
About the Statement Despite the advent of medical therapy for hypertension, population blood pressure control remains suboptimal. Limitations of medical therapy include cost, adverse side effects, limited access, and poor adherence. Renal denervation (RDN) is a minimally invasive, endovascular procedure targeting sympathetic nerves adjacent to the renal arteries. Disruption of these nerves has…
Source: scai.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
SCAI is seeking your comments on our upcoming Position Statement on #RenalDenervation for #Hypertension: Patient Selection, Best Practices for Optimal Techniques, Competence, Training and Organizational Recommendations. Feedback is requested by June 14 ➡️ https://t.co/Fgr1taaTd9 https://t.co/7Yi7HPHmh8
-
-
Mashup Score: 0
The findings validate the technique used by Medtronic and ReCor, while suggesting the U.S. companies will face competition if they target the Chinese market.
Source: MedTech DiveCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3New Statement for Public Comment | SCAI - 12 month(s) ago
About the Statement Despite the advent of medical therapy for hypertension, population blood pressure control remains suboptimal. Limitations of medical therapy include cost, adverse side effects, limited access, and poor adherence. Renal denervation (RDN) is a minimally invasive, endovascular procedure targeting sympathetic nerves adjacent to the renal arteries. Disruption of these nerves has…
Source: scai.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
What to look for heading into two long days of #FDA advisory committee meetings next week. [I'll be looking to pre-game this weekend with naps.] #renaldenervation #hypertension https://t.co/aIye8XI1Z1